Obtaining clinical trial approval (CTA)
CTA is a regulatory document sent to the National Health Authority stating that the sponsor intends to conduct a clinical trial of an IMP or an approved medicine in order to find a new indicator.
In order to be approved for clinical trials, the CTA application must include all necessary documents required by the National Health Authority. Rules for conducting clinical trials and safety requirements vary in different countries. The CTA is one of many important documents governing the conduct of clinical trials.
Let’s keep in touch!
Get the latest news about GCT and the projects we support in a monthly email. View the mailing archive